Krka, d. d. (KRK.WA)
Warsaw · PLN · Healthcare · Drug Manufacturers - Specialty & Generic
PLN 1,106.00 (-1.43%) as of
Key statistics
- Market cap
- 33.49B
- P/E (TTM)
- 18.91
- EPS (TTM)
- 58.48
- Dividend yield
- 3.51%
- 52-week range
- 810.00 – 1,200.00
- Beta
- 0.44
- Revenue (TTM)
- 2.11B
- Profit margin
- 19.78%
- Volume
- 18.00
About Krka, d. d.
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Novo Mesto, Slovenia
- Employees
- 13,300
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.